Leaderboards/epilepsy research and treatment

epilepsy research and treatment

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Valery L. Feigin
Auckland University of Technology
99
2
Xiaoshuai Cao
First Affiliated Hospital of Henan University of Science and Technology
90
3
John S. Duncan
National Hospital for Neurology and Neurosurgery
80
4
Ganqin Du
First Affiliated Hospital of Henan University of Science and Technology
80
5
Lizhen Xu
Guangxi University
70
6
Weiying Lin
Guangxi University
60
7
Riccardo De Giorgi
Oxford Health NHS Foundation Trust
50
8
Maxime Taquet
Oxford Health NHS Foundation Trust
40
9
Jian Zhang
Henan University
20
10
Sebastián Urbina Fredes
Metropolitan University of Technology
10

Rising Stars Papers

1
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
The Lancet Neurology|2024
1.1k cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Shams Forruque Ahmed
Asian University for Women
99
2
Amir Mohammad Nezhad Salari
Bam University of Medical Sciences
80
3
Matilde Leonardi
Fondazione IRCCS Istituto Neurologico Carlo Besta
70
4
Wen‐Jun Li
Central South University
60
5
Tomotaka Tanaka
Kyoto University
50
6
Alissa M. D’Gama
Harvard University
40
7
Mingkan Shen
University of Southern Queensland
30
8
Ruiqi Han
Henan University
30
9
Yaoqiang Du
Zhejiang Chinese Medical University
20
10
Hyun-Woo Kim
Pusan National University Yangsan Hospital
10

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Sameer M. Zuberi
Royal Hospital for Children
99
2
Torbjörn Tomson
Karolinska Institutet
90
3
Sophie Bennett
University College London
90
4
Jes Olesen
Glostrup Hospital
70
5
Theo Vos
University of Washington
60
6
Rosemarie Kobau
National Center for Chronic Disease Prevention and Health Promotion
50
7
Stefan Köhler
Western University
40
8
Julia Hippisley–Cox
University of Nottingham
30
9
István Módy
University of California, Los Angeles
20
10
Eileen P.G. Vining
Johns Hopkins University
10

All-Time Leaders Papers

1
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet|2017
13.5k cit.
2
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
The Lancet|2012
8.4k cit.
3
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
The Lancet|2016
7.4k cit.
4
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
The Lancet|2015
6.5k cit.
5
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet Psychiatry|2018
1.5k cit.
6
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
BMJ|2008
1.5k cit.
7
Disability weights for the Global Burden of Disease 2013 study
The Lancet Global Health|2015
1.2k cit.
8
Resolving the Fast Kinetics of Cooperative Binding: Ca2+ Buffering by Calretinin
PLoS Biology|2007
99 cit.
9
Distinct Familiarity-Based Response Patterns for Faces and Buildings in Perirhinal and Parahippocampal Cortex
Journal of Neuroscience|2013
77 cit.
10
The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study
BMJ Open|2014
68 cit.

Reagents for epilepsy research and treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

Phospho-Zap-70 (Tyr319)/Syk (Tyr352) (65E4) Rabbit Monoclonal Antibody (SignalFlex™ Pacific Blue™ Conjugate)

#39152$486
View Evidence →

⭐ Recommended

Best all-around

Agilent/Dako

Glial Fibrillary Acidic Protein (GFAP)

Cited in 5 papers
#M0761
View Evidence →Cell Signaling Technology

Caspase-3 (D3R6Y) Rabbit Monoclonal Antibody (IHC Formulated)

#14214$168
View Evidence →Cell Signaling Technology

MBNL1 Antibody

#94633$317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

CDK4 (D9G3E) Rabbit Monoclonal Antibody (PE Conjugate)

Cited in 12 papers
#42749$465
View Evidence →Cell Signaling Technology

BATF (F2L7C) Rabbit Monoclonal Antibody

Cited in 10 papers
#30889$178
View Evidence →Cell Signaling Technology

PU.1 (F2D5A) Mouse Monoclonal Antibody (PE Conjugate)

Cited in 9 papers
#57800$465
View Evidence →